<DOC>
	<DOC>NCT01192659</DOC>
	<brief_summary>The purpose of this study is to identify risk factors for low lymphocyte count among patients with type 2 diabetes who are treated with oral antidiabetic drugs.</brief_summary>
	<brief_title>Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes</brief_title>
	<detailed_description>Involving a secondary analysis of data collected prospectively from a defined cohort, for the SAVOR trial.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Lymphopenia</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>Enrolled in SAVOR Diagnosed with T2DM Baseline HbA1c â‰¥6.5% (based on the last measured and documented laboratory measurement within 6 months) Age 40 or older High risk for a cardiovascular event Not enrolled in SAVOR Current or previous treatment with DPP4 inhibitors and/or GLP1 or incretin mimetics. Acute vascular event Pregnancy HIV/AIDS Severe autoimmune disease Current chronic steroid use</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>